Health Catalyst Inc (NASDAQ: HCAT) closed the day trading at $5.67 down -6.90% from the previous closing price of $6.09. On the day, 1080678 shares were traded.
Ratios:
For a better understanding of HCAT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.39 and its Current Ratio is at 4.39. In the meantime, Its Debt-to-Equity ratio is 0.68 whereas as Long-Term Debt/Eq ratio is at 0.67.
On January 03, 2024, Evercore ISI Upgraded its rating to Outperform which previously was In-line but kept the price unchanged to $11.
On January 03, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $14.Barclays initiated its Overweight rating on January 03, 2024, with a $14 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 15 ’24 when Llewelyn Linda sold 2,005 shares for $7.80 per share. The transaction valued at 15,648 led to the insider holds 128,231 shares of the business.
Burton Daniel D. bought 26,200 shares of HCAT for $204,525 on Feb 27 ’24. The Chief Executive Officer now owns 1,172,623 shares after completing the transaction at $7.81 per share. On Feb 15 ’24, another insider, Llewelyn Linda, who serves as the Chief People Officer of the company, sold 3,262 shares for $9.77 each. As a result, the insider received 31,855 and left with 64,786 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.12 while its Price-to-Book (P/B) ratio in mrq is 0.90.
Stock Price History:
Over the past 52 weeks, HCAT has reached a high of $14.37, while it has fallen to a 52-week low of $5.99.
Shares Statistics:
A total of 58.30M shares are outstanding, with a floating share count of 55.71M. Insiders hold about 4.87% of the company’s shares, while institutions hold 86.97% stake in the company.
Earnings Estimates
Current recommendations for the stock of the company come from Caterpillar, Inc. analysts. The consensus estimate for the next quarter is $322.63, with high estimates of $0.95 and low estimates of $5.67.
Analysts are recommending an EPS of between $Technology and $Healthcare for the fiscal current year, implying an average EPS of $Healthcare.
